ATR-IN-4 is a potent cancer cells NCI-H460 with IC50s of 130.9 nM and 41 .33 nM, respectively. (Patent CN112142744A, compound 13)[1].
[1]. Substituted fused heteroaromatic bicyclic compounds as kinase inhibitors and uses thereof. CN112142744A.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 10mg | ¥8,640.00 | 现货 | 1 |
















ATR-IN-4 is a potent cancer cells NCI-H460 with IC50s of 130.9 nM and 41 .33 nM, respectively. (Patent CN112142744A, compound 13)[1].
[1]. Substituted fused heteroaromatic bicyclic compounds as kinase inhibitors and uses thereof. CN112142744A.